RSWM
ANIX icon

Robertson Stephens Wealth Management’s Anixa Biosciences ANIX Stock Holding History

Robertson Stephens Wealth Management’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.8K Hold
15,649
– – ﹤0.01% 635
2026
Q1 		$40.4K Hold
15,649
– – ﹤0.01% 608
2025
Q4 		$48.8K Hold
15,649
– – ﹤0.01% 634
2025
Q3 		$51.6K Hold
15,649
– – ﹤0.01% 525
2025
Q2 		$51.6K Hold
15,649
– – ﹤0.01% 542
2025
Q1 		$44.8K Hold
15,649
– – ﹤0.01% 537
2024
Q4 		$36.3K Hold
15,649
– – ﹤0.01% 553
2024
Q3 		$49.3K Sell
15,649
-10,000
-39% -$30.8K ﹤0.01% 614
2024
Q2 		$56.7K Buy
+25,649
New +$72.7K ﹤0.01% 488

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Robertson Stephens Wealth Management's ANIX Position: Q2 2026 in Review

Robertson Stephens Wealth Management held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 15,649 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Robertson Stephens Wealth Management first reported a position in ANIX in Q2 2024 and has held it in 9 quarters since. The position peaked at $56.7K in Q2 2024. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Robertson Stephens Wealth Management held 15,649 shares of Anixa Biosciences worth $43.8K as of Q2 2026.
  • Robertson Stephens Wealth Management left its Anixa Biosciences share count unchanged in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #635 holding.
  • Robertson Stephens Wealth Management first reported a position in Anixa Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Robertson Stephens Wealth Management's Anixa Biosciences position peaked at $56.7K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.